Stock News•2 months ago
Surrozen to Present at Upcoming Healthcare Investor Conference
Surrozen (Nasdaq: SRZN) management will present at an upcoming healthcare investor conference, a routine event for the biotech firm.
MarketLens
Surrozen's Insider Selling: A $7 Million Red Flag Amidst Biotech Optimism
1 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•2 months ago
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants
Q32 Bio priced a $200M public offering of ~11M shares and pre-funded warrants at $18.25/share, diluting existing holders to fund clinical development.
Stock News•2 months ago
What This Immunome Sale Means a Day Before a Big FDA Milestone
An Immunome insider sold 100K shares (~$2.4M) on July 6-7, 2026, representing 32% of their holdings, ahead of a major FDA milestone.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•1 hour ago
BABA 13-DAY DEADLINE ALERT: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 5, 2026 Lead Plaintiff Deadline
Stock News•2 hours ago
Nasdaq Scores Record As Oil Eases; Apple Tests Buy Point
Stock News•2 hours ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alibaba Group Holding Limited of Class Action Lawsuit and Upcoming Deadlines – BABA
Stock News•2 hours ago
Meta Was the Worst AI Lab
Stock News•3 hours ago